# Effect of Pentoxifylline on Preventing Chemotherapy-induced Toxicities in Patients With Breast Cancer

> **NCT06186700** · PHASE2 · COMPLETED · sponsor: **Mansoura University** · enrollment: 100 (actual)

## Conditions studied

- Breast Cancer Female
- Breast Cancer Patients
- Neoadjuvant Therapy
- Doxorubicin
- Taxane-induced Peripheral Neuropathy

## Interventions

- **DRUG:** Pentoxifylline 400mg plus chemotherapy
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT06186700
- **Lead sponsor:** Mansoura University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-25
- **Primary completion:** 2024-12-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06186700

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06186700, "Effect of Pentoxifylline on Preventing Chemotherapy-induced Toxicities in Patients With Breast Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06186700. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*